Traick AI focuses on artificial intelligence and medical image processing to speed up radiology workflows and improve patient care. Its core product is a clinical decision support platform that evaluates ultrasound scans of breast and thyroid nodules to identify malignancy risk, aiming to detect cancer at earlier stages while reducing invasive procedures and false positives. The system is designed to boost diagnostic accuracy for healthcare professionals. Following its latest funding, the company plans to accelerate R&D and certification of its thyroid and breast cancer analysis technology. Management also intends to expand the product’s footprint across European and UK markets. Although no revenue or user figures were disclosed, the company positions these funds as instrumental to scaling both technology and market reach.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2025